1. Home
  2. HROW vs SHO Comparison

HROW vs SHO Comparison

Compare HROW & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HROW

Harrow Inc.

N/A

Current Price

$30.61

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

N/A

Current Price

$11.31

Market Cap

2.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
HROW
SHO
Founded
1998
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2008
2004

Fundamental Metrics

Financial Performance
Metric
HROW
SHO
Price
$30.61
$11.31
Analyst Decision
Strong Buy
Buy
Analyst Count
9
12
Target Price
★ $65.00
$11.96
AVG Volume (30 Days)
486.5K
★ 1.6M
Earning Date
11-09-2026
11-06-2026
Dividend Yield
N/A
★ 3.21%
EPS Growth
★ 71.43
N/A
EPS
N/A
★ 0.22
Revenue
N/A
★ $1,115,167,000.00
Revenue This Year
$28.81
$2.47
Revenue Next Year
$53.97
N/A
P/E Ratio
★ N/A
$50.80
Revenue Growth
★ N/A
N/A
52 Week Low
$28.54
$8.69
52 Week High
$54.98
$12.07

Technical Indicators

Market Signals
Indicator
HROW
SHO
Relative Strength Index (RSI) 27.10 49.85
Support Level $28.54 $10.99
Resistance Level $35.43 $11.19
Average True Range (ATR) 1.25 0.17
MACD -0.21 0.03
Stochastic Oscillator 11.48 57.58

Price Performance

Historical Comparison
HROW
SHO

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

Share on Social Networks: